Perfil
Daniel Janse is currently the President & Chief Executive Officer at Affyimmune Therapeutics, Inc. He previously held positions as the Director at Cell Therapy Ltd. in 2011, Senior Director at Juno Therapeutics GmbH from 2016 to 2018, Managing Director at Northpond Ventures LLC in 2023, Senior Director at Johnson & Johnson Innovation from 2013 to 2016, Manager at McKinsey & Co., Inc. from 2008 to 2011, Investment Manager at Inventages Venture Capital Investment, Inc. from 2011 to 2013, and Chief Operating Officer at Arbor Biotechnologies, Inc. from 2020 to 2021.
Dr. Janse obtained his undergraduate degree from Brown University in 1998 and his doctorate degree from Harvard University in 2005.
Cargos activos de Daniel Janse
| Empresas | Cargo | Inicio |
|---|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | Director Ejecutivo | 15/07/2024 |
Antiguos cargos conocidos de Daniel Janse.
| Empresas | Cargo | Fin |
|---|---|---|
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures invests in companies located in the United States. The firm focuses on the science and technology sectors. It participates in early-stage capital transactions. | Director/Miembro de la Junta | 01/01/2023 |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Director de Operaciones | 31/05/2021 |
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Develops CAR-T therapy candidates for the treatment of various types of cancer | Inversor de Capital Privado | 31/07/2018 |
Johnson & Johnson Innovation LLC
Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Provides healthcare solutions and services | Inversor de Capital Privado | 30/09/2016 |
Inventages Venture Capital Investment, Inc
Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements. | Corporate Officer/Principal | 31/07/2013 |
Formación de Daniel Janse.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventages Venture Capital Investment, Inc
Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements. | Finance |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Johnson & Johnson Innovation LLC
Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Provides healthcare solutions and services | Health Services |
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Develops CAR-T therapy candidates for the treatment of various types of cancer | Health Technology |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Health Technology |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures invests in companies located in the United States. The firm focuses on the science and technology sectors. It participates in early-stage capital transactions. | Finance |
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | Commercial Services |
- Bolsa de valores
- Insiders
- Daniel Janse
















